Bladder cancer stage and outcome by array-based comparative genomic hybridization

Clinical Cancer Research

Volumn 11, Issue 19 I, 2005, Pages 7012-7022

  Blaveri, Ekaterini ^a   Brewer, Jeremy L ^a   Roydasgupta, Ritu ^b   Fridlyand, Jane ^b   Devries, Sandy ^a   Koppie, Theresa ^b   Pejavar, Sunanda ^a   Mehta, Kshama ^a   Carroll, Peter ^b   Simko, Jeff P ^a   Waldman, Frederic M ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARRAY BASED COMPARATIVE GENOMIC HYBRIDIZATION; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CLONE; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MICROARRAY; FOLLOW UP; GENOMIC INSTABILITY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MUSCLE METASTASIS; NONBIOLOGICAL MODEL; OUTCOMES RESEARCH; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; TUMOR CLASSIFICATION;

CHROMOSOME MAPPING; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CLUSTER ANALYSIS; DISEASE PROGRESSION; DNA; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LINKAGE (GENETICS); MULTIVARIATE ANALYSIS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 26444453688     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-0177     Document Type: Article

References (30)

1. Lee R, Droller MJ. The natural history of bladder cancer. Implications for therapy. Urol Clin North Am 2000; 27:1-13, vii.
2. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-21.
3. Kallioniemi A, Kallioniemi OP, Citro G, et al. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer 1995;12:213-9.
4. Veltman JA, Fridlyand J, Pejavar S, et al. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res 2003;63:2872-80.
5. Hurst CD, Fiegler H, Carr P, Williams S, Carter NP, Knowles MA. High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization. Oncogene 2004;23:2250-63.
6. Albertson DG, Ylstra B, Segraves R, et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 2000; 25:144-6.
7. Wilhelm M, Veltman JA, Olshen AB, et al. Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer. Cancer Res 2002;62:957-60.
8. Frederick L, Greene DLP, Irvin D, et al. editors. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag: 2002. p. 367.
9. Lopez-Beltran ASG, Gasser T, Hartmann A, et al. Infiltrating urothelial carcinoma. In: Eble JNSG, Epstein JI, Sesterhenn IA, editors. WHO pathology and genetics tumors of the urinary system and male genital organs; 2004. p. 93.
10. Snijders AM, Nowak N, Segraves R, et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet 2001;29:263-4.
11. Pinkel D, Segraves R, Sudar D, et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998;20:207-11.
12. Jain AN, Tokuyasu TA, Snijders AM, Segraves R, Albertson DG, Pinkel D. Fully automatic quantification of microarray image data. Genome Res 2002;12:325-32.
13. Fridlyand J, Snijders A, Pinkel D, Albertson DG, Jain AN. Application of hidden Markov models to the analysis of the array CGH data. J Multivariate Analysis 2004;90:132-53.
14. Nakao K, Mehta KR, Fridlyand J, et al. High-resolution analysis of DNA copy number alterations in cdorectal cancer by array-based comparative genomic hybridization. Carcinogenesis 2004;25:1345-57.
15. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A 2002;99:6567-72.
16. Orntoft TF, Wolf H. Molecular alterations in bladder cancer. Urol Res 1998;26:223-33.
17. Knowles MA. Molecular genetics of bladder cancer: pathways of development and progression. Cancer Surv 1998;31:49-76.
18. Tzai TS, Chen HH, Chan SH, et al. Clinical significance of allelotype profiling for urothelial carcinoma. Urology 2003;62:378-84.
19. Sengelov L, Christensen M, von der Maase HD, et al. Loss of heterozygosity at 1p, 8p, 10p, 13q, and 17p in advanced urothelial cancer and lack of relation to chemotherapy response and outcome. Cancer Genet Cytogenet 2000;123:109-13.
20. Simon R, Burger H, Semjonow A, Hertle L, Terpe HJ, Bocker W. Patterns of chromosomal imbalances in muscle invasive bladder cancer. Int J Oncol 2000;17:1025-9.
21. a). Cancer Res 1999;59:4658-61.
22. 1) urinary bladder cancer. Cancer Res 1999;59:5687-91.
23. Koo SH, Kwon KC, Ihm CH, Jeon YM, Park JW, Sul CK. Detection of genetic alterations in bladder tumors by comparative genomic hybridization and cytogenetic analysis. Cancer Genet Cytogenet 1999;110:87-93.
24. Simon R, Burger H, Brinkschmidt C, Bocker W, Hertle L, Terpe HJ. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J Pathol 1998;185:345-51.
25. Hovey RM, Chu L, Balazs M, et al. Genetic alterations in primary bladder cancers and their metastases. Cancer Res 1998;58:3555-60.
26. Muscheck M, Abol-Enein H, Chew K, et al. Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization. Carcinogenesis 2000;21:1721-6.
27. Cianciulli AM, Bovani R, Leonardo C, et al. DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH: prognostic implications. Eur J Histochem 2001;45:65-71.
28. Waldman FM, Carroll PR, Kerschmann R, Cohen MB, Field FG, Mayall BH. Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res 1991;51:3807-13.
29. Erill N, Colomer A, Verdu M, et al. Genetic and immunophenotype analyses of TP53 in bladder cancer: TP53 alterations are associated with tumor progression. Diagn Mol Pathol 2004;13:217-23.
30. von Knobloch R, Bugert P, Jauch A, Kalble T, Kovacs G. Allelic changes at multiple regions of chromosome 5 are associated with progression of urinary bladder cancer. J Pathol 2000;190:163-8.